-
Antalarmin (CP-156,181) is a drug that acts as a CRH1 antagonist. Corticotropin-releasing
hormone (CRH), also
known as Corticotropin-releasing factor,...
- research, with the best-known
agents being the
selective CRF-1
antagonist antalarmin and a
newer drug pexacerfont. A
recent human trial disappointingly found...
- the
treatment of
generalized anxiety disorder.
Another CRH-1
antagonist antalarmin has been researched[citation needed] in
animal studies for the treatment...
-
translate from
animal models, the
alcohol anti-craving
effects do not.
Antalarmin Corticotropin releasing hormone antagonists List of
investigational anxiolytics...
-
certain human po****tions.
Corticotropin releasing hormone antagonists Antalarmin CP-154,526
Emicerfont Verucerfont "International
Nonproprietary Names...
-
remains poorly understood.
Corticotropin releasing hormone antagonists Antalarmin Pexacerfont Verucerfont Hubbard CS,
Labus JS,
Bueller J,
Stains J, Suyenobu...
- 526 is
under investigation for the
potential treatment of alcoholism.
Antalarmin Pexacerfont Corticotropin releasing hormone antagonist Schulz DW, Mansbach...
- Corticotropin-releasing
hormone receptor Corticotropin-releasing
hormone antagonist Antalarmin Pexacerfont Verucerfont GRCm38:
Ensembl release 89: ENSMUSG00000018634...
- Corticotropin-releasing
hormone Sauvagine Stressin I
Urocortin Antagonists Antalarmin Astressin-B CP-154,526
Emicerfont Hypericin LWH-234 NBI-27914 NBI-74788...
- Corticotropin-releasing
hormone Sauvagine Stressin I
Urocortin Antagonists:
Antalarmin Astressin-B CP-154,526
Emicerfont Hypericin LWH-234 NBI-27914 NBI-74788...
